We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/4/2020 11:39 | Welcome SSB! Let’s hope we gain traction after this groundbreaking news. | ducatiman | |
20/4/2020 11:19 | Happy with today's news. | lr2 | |
20/4/2020 11:15 | Tom Oakley and Rory Shaw on Livestream. I'm not hearing Tom Oakley. | ged5 | |
20/4/2020 09:40 | A similar transformation is needed within secondary care, however this comes with additional complexity owing to the importance of medical imaging and other investigations as part of clinical decision making. As more staff have to self-isolate, we need tools that support remote working and facilitate better, more efficient collaboration amongst clinical colleagues. We must engage with clinicians who need to remain isolated, or who are in quarantine. Their expertise will help to ensure the NHS continues to deliver a high standard of on-going care while we overcome this crisis. It’s been humbling to see health techs all across the UK taking up this call-to-arms, supporting the NHS where they’re able to and showing how much value innovation can bring. | ged5 | |
20/4/2020 09:21 | Totally agree! | ged5 | |
20/4/2020 09:14 | This is pretty big news. It confirms that the pilot was well received (or they wouldn’t have asked for enhancements and rolled it out). Also interesting to find that it doesnt take long to tweak Bleepa. For anyone with a timescale greater than a month, this is in effect an accelerated successful trial with potentially huge free publicity. That doesnt happen often for any business. | yump | |
20/4/2020 09:07 | Traders bailing out, let’s see what happens when they are done. | ducatiman | |
20/4/2020 08:38 | Looks like the traders bailing out. The gamble paid off for them. Best wait until they finish then top up. This is his best RNS so far! | ged5 | |
20/4/2020 08:34 | Feedback? Fallback is more apt come on which private ones have been spiked this morning? | barnes4 | |
20/4/2020 08:33 | Nice start to a Monday | knowing | |
20/4/2020 08:20 | It is a start, only 200 clinicians, and I believe it is free to the NHS at the moment | sonie01 | |
20/4/2020 08:19 | Hey Duc, I just took a few as a bored punt on that RNS. | sideshowbull | |
20/4/2020 08:17 | A great start sonie!! | ducatiman | |
20/4/2020 08:09 | Morning dc your thoughts on today's news? | sonie01 | |
20/4/2020 07:21 | Wakey wakey | ducatiman | |
19/4/2020 15:16 | Next week is surely this week - come on Tom! “Imminent̶ | zooskeeper | |
19/4/2020 09:29 | The CE Mark is a self certificate where we provide lots of technical data to provide authentication. It's long process carried out by the software and technical team, the CE Mark for Texrad lung took some months due to low resource numbers. They may be supported by technical partners in this process to speed it up. | seppin | |
19/4/2020 08:39 | “Imminent̶ | ducatiman | |
18/4/2020 00:40 | Always next week !! | stalker_boy | |
17/4/2020 16:28 | Hope you have a good weekend too. Keep safe. | lr2 | |
17/4/2020 16:23 | Well have a good weekend. Maybe news next week. Well it was imminent 2 weeks ago! | ged5 | |
17/4/2020 16:16 | You are too gracious. Think the move down is mostly the bots looking to take a few shares onto their books. | lr2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions